Meet the Team

We have a highly talented team who are passionate about researching and developing systematic trading strategies and infrastructure.

Meet the Team

We have a highly talented team who are passionate about researching and developing systematic trading strategies and infrastructure.

  • DR EWAN KIRK

    DR EWAN KIRK

    President – GAM Systematic

    Dr Ewan Kirk is the President of GAM Systematic. He co-founded Cantab Capital Partners in 2006, which became part of GAM Systematic in October 2016. His daily focus is research and development, risk management and managing the Cantab quantitative team. Prior to founding Cantab, Ewan Kirk ran the 120-strong Goldman Sachs Strategies Group in Europe, where he was responsible for all of Goldman Sachs’ quantitative technology. Ewan Kirk holds a PhD in Mathematics (General Relativity) from the University of Southampton, a Certificate in Advanced Study in Applied Mathematics from the University of Cambridge and achieved a First Class degree in Natural Philosophy and Astronomy at the University of Glasgow.
  • DR FREDERIC DESOBRY

    DR FREDERIC DESOBRY

    CO-CHIEF INVESTMENT OFFICER

    Dr Frédéric Desobry is co-CIO for GAM Systematic's Cambridge team. Frédéric joined GAM Systematic in September 2019 after spending three years at Systematica Investments in Geneva and London as head of equity research. Prior to that, he was a quantitative analyst then a portfolio manager at Bluecrest Capital. Frédéric began his career at Global Advisors, a commodity-specialist CTA based in New York and London. Overall, Frédéric has spent over eleven years designing and managing all aspects of the systematic trading strategies' lifecycle. Frédéric holds Masters and a PhD in Signal Processing (Machine Learning) from the École Centrale Nantes and he spent five years as a Research Associate at the University of Cambridge.
  • DR TOM HOWAT

    DR TOM HOWAT

    Co-Chief Investment Officer

    Dr Tom Howat is co-CIO of GAM Systematic Cambridge. Prior to this, he was chief technology officer of Cantab Capital Partners, which became part of GAM Systematic in October 2016. Tom and Dr Matthew Killeya (Co-CIO) take overall responsibility for the investment and research process across the full suite of GAM Systematic Cambridge products. Tom heads up the team of scientists responsible for ongoing infrastructure development. Much of the framework underpinning all of the GAM Systematic Cambridge team’s critically important functions has been designed by Tom and his team. This includes the back-testing systems; trading and automated execution; real-time risk management and signal computation; trade allocations between different managed accounts etc. Tom joined Cantab at inception. Prior to this, Tom spent seven years at Trinity College, Cambridge, where he obtained degrees in Mathematics and a PhD in Mathematical Biology.
  • THE SCIENTISTS

    THE SCIENTISTS

    The heart of our business

    Over half of our employees are engaged in research and development – it is absolutely central to what we do.
    GAM Systematic Cambridge deliberately focuses on attracting top scientists from a wide variety of backgrounds, rather than primarily from other investment houses.  This broad range of experience has enabled us to think differently and as a result build portfolios with limited correlation to major systematic indices and to our biggest competitors in the space.
    GAM Systematic Cambridges's team combines a diverse skill set, with the common denominator being academic excellence and collegial team spirit.  We believe that a collaborative atmosphere and the spirit of team work are ingrained in GAM Systematic Cambridges’s psyche and underpin our investment philosophy.

Disclaimer

This website is issued in the United Kingdom by GAM Systematic LLP which is regulated in the conduct of its investment business by the FCA.
Any investments or investment services mentioned in this website are not available to private customers. Any funds managed by GAM Systematic LLP are not being marketed in EU or EEA jurisdictions other than any Approved AIFMD Jurisdiction (as defined below) and any EU or EEA investor other an Approved AIFMD Jurisdiction investor who wishes to obtain information on GAM Systematic LLP funds will only be provided any such materials upon receipt by GAM Systematic LLP of an appropriate reverse solicitation request in accordance with the requirements of the EU AIFM Directive and national law in their home jurisdiction.  The following is an "Approved AIFMD Jurisdiction" for the foregoing purposes: the United Kingdom, Sweden, Finland. The representative of the relevant Fund in Switzerland (the “Representative in Switzerland”) is Société Générale, Paris, Zurich Branch, Talacker 50, 8001 Zurich. The paying agent of the relevant Fund in Switzerland is Société Générale, Paris, Zurich Branch, Talacker 50, 8001 Zurich. In respect of the Shares distributed in Switzerland, the place of performance and jurisdiction is at the registered office of the Representative in Switzerland.

This financial promotion is issued by GAM Systematic LLP which is authorised and regulated by the Financial Conduct Authority ("FCA"). The funds managed by GAM Systematic LLP (the "Funds") are defined as "Unregulated Collective Investment Schemes" ("UCIS") and the promotion of a UCIS either within the UK or from the UK is severely restricted by statute. Consequently, this document is only made available to professional clients and eligible counterparties as defined by the FCA. Shares in the Funds should only be purchased by persons with professional experience of participating in unregulated schemes and any other person who receives this document should not rely upon it.
The distribution of the information contained in this website in certain countries may be restricted by law and persons who access it are required to inform themselves and to comply with any such restrictions. This information does not constitute an offer or solicitation in any jurisdiction. Prospective investors should inform themselves as to applicable legal requirements, exchange control regulations and taxes in the countries of their citizenship, residence or domicile.

This website is published solely for informational purposes and has no regard to the specific investment objectives, financial situation or particular needs of any person. Information contained herein is believed to be reliable but no warranty is given as to its accuracy or completeness and views and opinions, whilst given in good faith, are subject to change without notice.

The entire contents of the www.cantabcapital.com Internet site (the "site") are subject to copyright with all rights reserved. You may download or print individual sections of the site for your personal use and information only provided that you retain all copyright and other proprietary notices. You may not reproduce (in whole or in part), transmit (by electronic means or otherwise), modify, link into or use for any public or commercial purpose the site without the prior written permission of GAM Systematic LLP. You must not transmit any virus or other item of a destructive nature to the site and it is your responsibility to ensure that whatever you download or select for your use from the site is free from such items.
Where an unauthorised link to a non-GAM Systematic LLP website exists, GAM Systematic LLP does not accept responsibility for the content of such site nor the products, services or other items offered through that site.
This website is established in England by GAM Systematic LLP in accordance with and shall be governed by, and your browsing in and use of the site shall be deemed acceptance of, the laws of England and Wales. A condition of using the Site is that in the event of any dispute or proceeding you irrevocably submit to the exclusive jurisdiction of the English Courts and waive any objection to proceedings in such courts on the grounds of venue or on the grounds that the proceedings have been brought in an inconvenient forum.

GAM Systematic LLP; City House, 126-130 Hills Road, Cambridge, CB2 1RE, UK
Registered in England No: OC317557
Thank you for visiting Cantab Capital Partners.